Abstract: The present invention relates to the use of therapeutic compounds in the modification of T-cells, T-cell-antigen presenting cell (APC) interactions and the interaction between pathogenic organism and immunocompetent cells of a host. In particular, it relates to the use of these compounds in the modulation of the interaction between Notch proteins and their ligands and to the use of such compounds in the therapy of conditions such as graft rejection, autoimmunity, allergy, asthma and infectious diseases.
Type:
Grant
Filed:
May 4, 1999
Date of Patent:
May 3, 2005
Assignee:
Lorantis Limited
Inventors:
Jonathan Robert Lamb, Margaret Jane Dallman, Gerard Francis Hoyne